Istraživači
Popović, Lazar
Godina
- 42 2020 - 2027
- 38 2010 - 2019
Mp-kat.
- 23 M30/M60
- 19 M21 - Vodeći međunarodni časopis kategorije M21
- 14 M23 - Međunarodni časopis kategorije M23
- 8 M22 - Međunarodni časopis kategorije M22
- 5 M21a - Vodeći međunarodni časopis kategorije M21a
- 4 M21a+ - Vodeći međunarodni časopis kategorije M21a+
- 3 M10/M40
- 2 M20/M50
- 1 M34 - Saopštenje sa međ. skupa štampano u izvodu
- 1 M52 - Nacionalni časopis kategorije M52
- sledeći >
Godina - raspon
Rezultati 1-20 od 80
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2026 | Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study | D'arrigo, Corrado; ...; Medic-Milijic, Natasa; ...; Popovic, Lazar | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2026 | Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer![]() | Cvetanovic, Ana S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2026 | Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results![]() | Popovic, Lazar | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2025 | Immunotherapy maintenance versus immunotherapy after progression on platinum-based chemotherapy in the treatment of locally advanced or metastatic urothelial cancer![]() | Popovic, Lazar | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Comparation between treatment outcomes among patients with diffuse-large B-cell lymphoma treated between 2003-2010 and 2017-2021 treated with rituximab-based immunochemotherapy![]() | Đurić, Stefan; Popovic, Maja | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset![]() | Rizzo, Alessandro; ...; Popovic, Lazar S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2025 | Treatment Sequencing in Metastatic HR+/HER2-Breast Cancer: A Delphi Consensus![]() | Popovic, Lazar S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2025 | Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience![]() | Rizzo, Mimma; ...; Popovic, Lazar | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2025 | Second line treatment of clear cell renal cell carcinoma after progression on a tyrosine kinase inhibitor![]() | Popovic, Maja | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | First experience with antibody-drug conjugates trastuzumab deruxtecan and sacituzumab-govitecan in heavily pretreated patients with metastatic breast cancer![]() | Popovic, Lazar | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA![]() | Bozovic-Spasojevic, I | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Barriers related to adherence and implementation of the ESMO clinical practice guidelines: A survey provided by the ESMO community oncologists task force![]() | Liposits, GI; Indini, A; Papakonstantinou, A; Tan, ABT; Petrova, M; Pellegrino, B; Scholl, K; Popovic, Lazar S
Brasiuniene, B; Bennouna, J; Smyth, E; Vidra, RA;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab![]() | Incorvaia, Lorena; ...; Popovic, Lazar | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2024 | Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review![]() | Cvetanovic, Ana S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2024 | Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies![]() | Borstnar, Simona; Božović Spasojević, Ivana; Cvetanović, Ana | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2024 | Follicular lymphoma and chronic lymphocytic leukemia, 10 years, single institution![]() | Nikin, Zoran; Ivkovic-Kapic, Tatjana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2024 | Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study![]() | Massari, Francesco; ...; Popovic, Lazar S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2024 | The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs![]() | Sabale, Ugne; Karamousouli, Eugenia; Popovic, Lazar S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2024 | Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology![]() | Agostinetto, Elisa; ...; Popovic, L | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2024 | Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study![]() | Rizzo, Mimma; ...; Popovic, Lazar S | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
